title: Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
authors.forename: P
authors.initials: P
authors.lastname: Watson
authors.forename: N
authors.initials: N
authors.lastname: Simler
authors.forename: N
authors.initials: N
authors.lastname: Screaton
authors.forename: M
authors.initials: M
authors.lastname: Lillicrap
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003937:Diagnosis, Differential; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008171:Lung Diseases / Q000139:chemically induced*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor; D012218:Rheumatoid Nodule / Q000139:chemically induced*; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept